Moore DL - Search Results

1

The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009-2015).

Katz KC, Golding GR, Choi KB, Pelude L, Amaratunga KR, Taljaard M, Alexandre S, Collet JC, Davis I, Du T, Evans GA, Frenette C, Gravel D, Hota S, Kibsey P, Langley JM, Lee BE, Lemieux C, Longtin Y, Mertz D, Mieusement LMD, Minion J, Moore DL, Mulvey MR, Richardson S, Science M, Simor AE, Stagg P, Suh KN, Taylor G, Wong A, Thampi N; Canadian Nosocomial Infection Surveillance Program. Katz KC, et al. Among authors: moore dl. CMAJ. 2018 Jun 25;190(25):E758-E765. doi: 10.1503/cmaj.180013. CMAJ. 2018. PMID: 29941432 Free PMC article.

2

Vancomycin-resistant enterococci in Canada: results from the Canadian nosocomial infection surveillance program, 1999-2005.

Ofner-Agostini M, Johnston BL, Simor AE, Embil J, Matlow A, Mulvey M, Ormiston D, Conly J; Canadian Nosocomial Infection Surveillance Program. Ofner-Agostini M, et al. Infect Control Hosp Epidemiol. 2008 Mar;29(3):271-4. doi: 10.1086/528812. Infect Control Hosp Epidemiol. 2008. PMID: 18241031

3

Infection control practices related to Clostridium difficile infection in acute care hospitals in Canada.

Gravel D, Gardam M, Taylor G, Miller M, Simor A, McGeer A, Hutchinson J, Moore D, Kelly S, Mulvey M; Canadian Nosocomial Infection Surveillance Program. Gravel D, et al. Am J Infect Control. 2009 Feb;37(1):9-14. doi: 10.1016/j.ajic.2008.07.012. Am J Infect Control. 2009. PMID: 19171246

4

Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study.

Gravel D, Miller M, Simor A, Taylor G, Gardam M, McGeer A, Hutchinson J, Moore D, Kelly S, Boyd D, Mulvey M; Canadian Nosocomial Infection Surveillance Program. Gravel D, et al. Clin Infect Dis. 2009 Mar 1;48(5):568-76. doi: 10.1086/596703. Clin Infect Dis. 2009. PMID: 19191641

5

The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.

Bettinger JA, Scheifele DW, Le Saux N, Halperin SA, Vaudry W, Tsang R; Canadian Immunization Monitoring Program, Active (IMPACT). Bettinger JA, et al. Pediatr Infect Dis J. 2009 Mar;28(3):220-4. doi: 10.1097/INF.0b013e31819040e7. Pediatr Infect Dis J. 2009. PMID: 19209096

6

Study of cerebrospinal fluid shunt-associated infections in the first year following placement, by the Canadian Nosocomial Infection Surveillance Program.

Langley JM, Gravel D, Moore D, Matlow A, Embree J, MacKinnon-Cameron D, Conly J; Canadian Nosocomial Infection Surveillance Program. Langley JM, et al. Infect Control Hosp Epidemiol. 2009 Mar;30(3):285-8. doi: 10.1086/593969. Infect Control Hosp Epidemiol. 2009. PMID: 19215195

7

Surveillance for healthcare-acquired febrile respiratory infection in pediatric hospitals participating in the Canadian Nosocomial Infection Surveillance Program.

Vayalumkal JV, Gravel D, Moore D, Matlow A; Canadian Nosocomial Infection Surveillance Program. Vayalumkal JV, et al. Infect Control Hosp Epidemiol. 2009 Jul;30(7):652-8. doi: 10.1086/598247. Infect Control Hosp Epidemiol. 2009. PMID: 19496653

8

Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006.

Adam HJ, Louie L, Watt C, Gravel D, Bryce E, Loeb M, Matlow A, McGeer A, Mulvey MR, Simor AE; Canadian Nosocomial Infection Surveillance Program. Adam HJ, et al. Antimicrob Agents Chemother. 2010 Feb;54(2):945-9. doi: 10.1128/AAC.01316-09. Epub 2009 Nov 30. Antimicrob Agents Chemother. 2010. PMID: 19949062 Free PMC article.

9

Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.

Miller M, Gravel D, Mulvey M, Taylor G, Boyd D, Simor A, Gardam M, McGeer A, Hutchinson J, Moore D, Kelly S. Miller M, et al. Clin Infect Dis. 2010 Jan 15;50(2):194-201. doi: 10.1086/649213. Clin Infect Dis. 2010. PMID: 20025526

10

Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates.

Walkty A, Boyd DA, Gravel D, Hutchinson J, McGeer A, Moore D, Simor A, Suh K, Taylor G, Miller M, Mulvey MR; Canadian Nosocomial Infection Surveillance Program. Walkty A, et al. Diagn Microbiol Infect Dis. 2010 Apr;66(4):419-24. doi: 10.1016/j.diagmicrobio.2009.12.002. Diagn Microbiol Infect Dis. 2010. PMID: 20226332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters